VTGN
Vistagen Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.61
-0.02 ▼ -3.73%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$0.61
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.58 | Insider Own | 14.79% | Shs Outstand | 0.04B | Perf Week | -0.07% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | 41.74% | Insider Trans | - | Shs Float | 0.03B | Perf Month | 6.08% |
| Enterprise Value | -0.04B | PEG | - | EPS next Q | -0.32 | Inst Own | 24.75% | Short Float | 4.5% | Perf Quarter | -86.59% |
| Income | -0.05B | P/S | 34.37 | EPS this Y | -5.81% | Inst Trans | -16.34% | Short Ratio | 0.55 | Perf Half Y | -82.65% |
| Sales | 0.00B | P/B | 0.47 | EPS next 5Y | 12.86% | ROA | -42.35% | Short Interest | 1.52M | Perf YTD | -8.25% |
| Book/sh | 1.29 | P/C | 0.39 | EPS past 3/5Y | 39.12% 35.63% | ROE | -46.28% | 52W High | -88.18% ($5.14) | Perf Year | -77.67% |
| Cash/sh | 1.56 | P/FCF | - | Sales past 3/5Y | -24.04% - | ROIC | -92.12% | 52W Low | 41.23% ($0.43) | Perf 3Y | -86.53% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 54.91% | Gross Margin | 11.86% | Volatility(W/M) | 7.13% 9.03% | Perf 5Y | -99.14% |
| Dividend TTM | - | EV/Sales | -51.83 | Sales Y/Y TTM | -33% | Oper. Margin | -7566.52% | ATR (14) | 0.05 | Perf 10Y | -99.75% |
| Dividend Ex-Date | - | Quick Ratio | 4.67 | EPS Q/Q | -5.77% | Profit Margin | -6774.22% | RSI (14) | 44.53 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.67 | Sales Q/Q | 65.57% | SMA20 | 4.01% ($0.59) | Beta | 0.29 | Target Price | $0.97 |
| Payout | - | Debt/Eq | 0.03 | Earnings | 2000000 | SMA50 | -0.29% ($0.61) | Rel Volume | 0.17 | Prev Close | $0.63 |
| Employees | 57 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | 7.58% -16.85% | SMA200 | -75.92% ($2.53) | Avg Volume(3M) | 2.78M | Price | $0.61 |
| IPO | 2011/6/21 | Option/Short | Yes/Yes | Trades | 1246 | Volume | 471,390 | Change | -3.73% |
뉴스 로딩 중...